Skip to main content

All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:

General domain:

Specific domain:

Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness

KCE Reports 316 (2019)

https://kce.fgov.be/en/bariatric-surgery-an-hta-report-on-the-efficacy-safety-and-cost-effectiveness
Responsible use of high-risk medical devices: the example of 3D printed medical devices

KCE Reports 297 (2018) 3D printing is generating increased interest in the medical sector, namely in orthopaedics and dentistry, but there is no evidence that 3D-printed implants are as effective or safe as “classical” products. Yet they can currently be used without restrictions by doctors, even when they are “at high risk” (that is, more often than not, implantable).

https://kce.fgov.be/en/responsible-use-of-high-risk-medical-devices-the-example-of-3d-printed-medical-devices
How to improve the Belgian process for Managed Entry Agreements? An analysis of the Belgian and international experience

KCE Reports 288 (2017)

https://kce.fgov.be/en/how-to-improve-the-belgian-process-for-managed-entry-agreements-an-analysis-of-the-belgian-and
Bevacizumab in the treatment of ovarian cancer

KCE Reports 285 (2017)

https://kce.fgov.be/en/bevacizumab-in-the-treatment-of-ovarian-cancer
Left ventricular assist devices in the treatment of end-stage heart failure

KCE Reports 264 (2016)

https://kce.fgov.be/en/left-ventricular-assist-devices-in-the-treatment-of-end-stage-heart-failure
Towards a better managed off-label use of drugs

KCE Reports 252 (2015)

https://kce.fgov.be/en/towards-a-better-managed-off-label-use-of-drugs
Towards a guided and phased introduction of high-risk medical devices in Belgium

KCE Reports 249 (2015)

https://kce.fgov.be/en/towards-a-guided-and-phased-introduction-of-high-risk-medical-devices-in-belgium
Publicly funded Practice-oriented Clinical Trials

KCE Reports 246 (2015)

https://kce.fgov.be/en/publicly-funded-practice-oriented-clinical-trials
Cardiovascular pre-participation screening in young athletes

KCE Reports 241 (2015) About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?

https://kce.fgov.be/en/cardiovascular-pre-participation-screening-in-young-athletes
The non-invasive prenatal test (NIPT) for trisomy 21 – health economic aspects

KCE Reports 222 (2014)

https://kce.fgov.be/en/the-non-invasive-prenatal-test-nipt-for-trisomy-21-%E2%80%93-health-economic-aspects
Extremity-only MRI

KCE Reports 205 (2013)

https://kce.fgov.be/en/extremity-only-mri
Catheter ablation of atrial fibrillation

KCE Reports 184 (2012)

https://kce.fgov.be/en/catheter-ablation-of-atrial-fibrillation
Belgian guidelines for economic evaluations and budget impact analyses: second edition

KCE Reports 183 (2012)

https://kce.fgov.be/en/belgian-guidelines-for-economic-evaluations-and-budget-impact-analyses-second-edition
Transcatheter Aortic Valve Implantation (TAVI): a Health Technology Assessment Update

KCE Reports 163 (2011)

https://kce.fgov.be/en/transcatheter-aortic-valve-implantation-tavi-a-health-technology-assessment-update
The pre-market clinical evaluation of innovative high-risk medical devices

KCE Reports 158 (2011)

https://kce.fgov.be/en/the-pre-market-clinical-evaluation-of-innovative-high-risk-medical-devices
Cardiac resynchronisation therapy. A health technology assessment

KCE Reports 145 (2010)

https://kce.fgov.be/en/cardiac-resynchronisation-therapy-a-health-technology-assessment
Pacemaker therapy for bradycardia in belgium

KCE Reports 137A (2010)

https://kce.fgov.be/en/pacemaker-therapy-for-bradycardia-in-belgium
[Is neonatal screening for cystic fibrosis recommended in Belgium?]

KCE Reports 132 (2010)

https://kce.fgov.be/en/is-neonatal-screening-for-cystic-fibrosis-recommended-in-belgium
[Feasibility study of the introduction of an all-inclusive case-based hospital financing system in Belgium]

KCE Reports 121 (2010)

https://kce.fgov.be/en/feasibility-study-of-the-introduction-of-an-all-inclusive-case-based-hospital-financing-system-in
Endobronchial valves in the treatment of severe pulmonary emphysema: a rapid Health Technology Assessment

KCE Reports 114 (2009)

https://kce.fgov.be/en/endobronchial-valves-in-the-treatment-of-severe-pulmonary-emphysema-a-rapid-health-technology